Discovery of Novel Insulin-Like Growth Factor-1 Receptor Inhibitors with Unique Time-Dependent Binding Kinetics

Citations Over TimeTop 17% of 2013 papers

Abstract

This letter describes a series of small molecule inhibitors of IGF-1R with unique time-dependent binding kinetics and slow off-rates. Structure-activity and structure-kinetic relationships were elucidated and guided further optimizations within the series, culminating in compound 2. With an IGF-1R dissociative half-life (t 1/2) of >100 h, compound 2 demonstrated significant and extended PD effects in conjunction with tumor growth inhibition in xenograft models at a remarkably low and intermittent dose, which correlated with the observed in vitro slow off-rate properties.

Related Papers

• → Stimulation of Bone Matrix Appositionin Vitroby Local Growth Factors: A Comparison between Insulin-like Growth Factor I, Platelet-Derived Growth Factor, and Transforming Growth Factor β*(1990)211 cited
• → The Role of Target Binding Kinetics in Drug Discovery(2015)52 cited
• → Beyond Thermodynamics: Drug Binding Kinetics Could Influence Epidermal Growth Factor Signaling(2009)16 cited
• → Insulin-like Growth Factor I and Insulin and Their Abuse in Sport(2010)10 cited
• → Experimental Methods to Determine Binding Kinetics(2015)4 cited